← BackHAWKINS INC · Chemicals & Allied ProductsHWKN
Low riskNext report: Around Jan 27, 2027 (est.)
The short versionA profitable company with growing sales.
Going well
- Sales up 12% in the latest quarter vs a year ago
- Profitable
- Sales up 11% last year
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 0.9% from their holdings in the quarter ending June 2026 (162 bought, 134 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$135.66+2.6% that day
- Company value
- $2.8B
- Share price times all shares
- Price vs profit (P/E)
- 32.9x
- You pay about $33 for each $1 of yearly profit
- Price vs sales
- 2.5x
- Company value is 2.5 times a year of sales
- Dividend yield
- 0.6%
- Yearly dividend as a share of today's price
- Cash vs value
- 0%
- Cash as a share of company value
- Debt vs value
- 9%
- Debt as a share of company value
From HWKN's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Sep '26$313.8M+12% vs a year earlier
Dec '23Tap a barSep '26
Last 12 months: $1.1B, up 9.0% from the 12 months before. Over 5 years, sales grew about 13% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.16.7%
- MissDebt under half of equityNot relying on borrowed money.0.51x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.7.5%
- MissProfitable every yearSteady profits, not one good year.9 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$86.1M
- PassShare count not growingNot diluting owners. Falling means buybacks.-0.7% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.22.6%
- Revenue
- $1.1B
- +11.2% vs prior year
- 5-year growth
- +12.7%/yr
- revenue, per year
- Total debt
- $264.0M
- 0.51x equity
- Current ratio
- 2.35x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Sep 27, 2026Reported Oct 26After close4:13 pm ET - Revenue
- $313.8M
- +11.9% YoY
- EPS
- $1.34
- vs $1.08
- Op. margin
- 13.4%
- +1.3 pts
- Gross margin
- 24.4%
- +0.3 pts
- Free cash flow
- $29.6M
- Share count
- -0.3%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
63/ 100
- This week
- 2
- Normal week
- 1.2
- vs normal
- 1.7x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-0.9%Institutions cut 0.9% from their holdings. 162 bought, 134 sold. 2 quarters of net selling in a row.
Shares held by institutions16.3M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.2%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.4x · $229.0M debtShares outstandingLatest reported
21MNext reportAround Jan 27, 2027 (est.)Estimated from the same quarter last year
- Results filedOct 26
- Results filedJul 29
- Results filedMay 13
- Results filedJan 28
- Results filedOct 29, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.